|
Volumn 75, Issue 6, 2001, Pages 1111-1118
|
Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: A comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG
a |
Author keywords
Anovulation; Efficacy; Ovulation induction; rhCG; rhFSH; Safety; uhCG
|
Indexed keywords
CHORIONIC GONADOTROPIN;
OVRIDEL;
PROGESTERONE;
RECOMBINANT CHORIONIC GONADOTROPIN;
RECOMBINANT FOLLITROPIN;
UNCLASSIFIED DRUG;
URINARY HUMAN CHORIONIC GONADOTROPIN;
ADULT;
ANOVULATION;
ARTICLE;
BLOOD SAMPLING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
OVARY FOLLICLE;
OVULATION;
OVULATION INDUCTION;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGESTERONE BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
WORLD HEALTH ORGANIZATION;
ADULT;
ANOVULATION;
CHORIONIC GONADOTROPIN;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLICLE STIMULATING HORMONE;
HUMANS;
OVARIAN FOLLICLE;
OVULATION;
OVULATION INDUCTION;
PREGNANCY;
PREGNANCY OUTCOME;
RECOMBINANT PROTEINS;
SAFETY;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
|
EID: 0034994280
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/S0015-0282(01)01803-9 Document Type: Article |
Times cited : (58)
|
References (12)
|